CHINO HILLS, CA, United States, via ETELIGIS INC., 10/29/2014 – – KollagenX Corp. (OTCQB: KGNX), an advanced skin care development and marketing company, today announced that KollagenX 24KT Nano Gold Eye Serum is now available for purchase at select Costco Canada stores.
“After successfully navigating an exhaustive new product vetting process from this very demanding global retailer, we are extremely proud that our KollagenX® 24KT Gold Eye Serum is now available for purchase across Canada at select Costco stores,” stated Rondell Fletcher, President of KollagenX Corp. “Now thousands of Canadian shoppers will have the opportunity to try this innovative anti-wrinkle skin care product for the first time and experience the amazing scientifically proven effects for themselves. We know that both men and women will love what it does for their skin.”
KollagenX® 24KT Gold Eye Serum is a luxurious skin care treatment formulated to help rediscover your skin’s youthful strength, firmness and resilience. Thanks to the unique effect of collagen infused with 24-karat natural gold, this anti-wrinkle treatment is scientifically proven to smooth away the signs of aging and give you an enriched refreshing glow instantly.
Fletcher concluded, “We hope this is the beginning of a long and prosperous relationship with Costco Canada, their loyal customers, and potentially additional Costco stores and skin care/cosmetics retailers in other countries as well.”
KollagenX® is a California-based cosmetic company whose main focus is Nano Gold Technology also known as NGT®. Founded in 2008 by Rondell Fletcher and George Huerta, KollagenX® develops and introduces new, safe, and more affordable eco-friendly NGT® products that will help improve the quality of lives. The Company’s unique anti-aging skin care products help to restore a natural youthful glow and a smoother, suppler appearance. KollagenX helps bring the nourishment your skin needs to be healthier and function more effectively.
For more information on KollagenX Corp., visit www.kollagenx.com.
Any statements made in this press release which are not historical facts contain certain forward-looking statements; as such term is defined in the Private Security Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company’s operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.
KollagenX, Inc. – Investor Relations
(888) 676-8880 (Toll-free)
SOURCE: KollagenX, Inc.